Publications by authors named "Stephanie Corjon"

Claim this Profile
C
Cell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interaction.
Stéphanie Corjon, Gaëlle Gonzalez, Petra Henning, Alexei Grichine, Leif Lindholm

PLoS One· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capsomer-specific fluorescent labeling of adenoviral vector particles allows for detailed analysis of intracellular particle trafficking and the performance of bioresponsive bonds for vector capsid modifications.
Sigrid Espenlaub, Stéphanie Corjon, Tatjana Engler, Carolin Fella, Manfred Ogris

Hum Gene Ther· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved adenovirus type 5 vector-mediated transduction of resistant cells by piggybacking on coxsackie B-adenovirus receptor-pseudotyped baculovirus.
Ophélia Granio, Marine Porcherot, Stéphanie Corjon, Kuntida Kitidee, Petra Henning

J Virol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reductive amination as a strategy to reduce adenovirus vector promiscuity by chemical capsid modification with large polysaccharides.
Sigrid Espenlaub, Andreas Wortmann, Tatjana Engler, Stéphanie Corjon, Stefan Kochanek

J Gene Med· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of adenovirus vectors to the LRP receptor family with the high-affinity ligand RAP via combined genetic and chemical modification of the pIX capsomere.
Stéphanie Corjon, Andreas Wortmann, Tatjana Engler, Nico van Rooijen, Stefan Kochanek

Mol Ther· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies.
Andreas Wortmann, Sabine Vöhringer, Tatjana Engler, Stephanie Corjon, Reinhold Schirmbeck

Mol Ther· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis